To systematically review the methodologic quality of, and summarize the evidence from trials examining the effectiveness of physical exercise in improving the level of physical functioning and psychological well-being of cancer patients during and after medical treatment.
INTRODUCTION
Cancer and its treatment are associated with numerous physical and psychological symptoms and adverse effects. [1] [2] [3] Exercise has been proposed as a promising strategy for the treatment of some of these physical and psychological complaints, and various exercise interventions are currently available for use both during and after cancer treatment.
4-8 One of the major challenges for researchers in the field of rehabilitation is to provide empirical evidence of the efficacy of these programs. Earlier work has reviewed the evidence regarding physical exercise and health-related quality of life (HRQOL) in cancer patients during and after treatment. [9] [10] [11] [12] [13] [14] [15] [16] [17] These reviews found evidence supportive of the role of exercise in attenuating a range of physical and psychosocial problems associated with cancer and its treatment, but also indicated numerous methodologic limitations that hampered the interpretation of the results of the studies. The most common limitations reported were the use of small convenience samples resulting in limited statistical power, the absence of appropriate control groups, and the diversity of measures that made it difficult to compare results across studies.
Well-designed and properly executed randomized controlled trials (RCTs) provide the best evidence on the effectiveness of health care interventions. Trials with inadequate methodologic approaches may produce exaggerated treatment effects and biased results, and may lead to misinformed decision making at all levels of health care, from treatment decisions for the individual patient to the formulation of national public health policies. Critical appraisal of the quality of clinical trials is possible only if the design, conduct, and analysis of RCTs are described thoroughly and accurately in published reports. Unfortunately, the reporting of RCTs is often incomplete and thus may obfuscate problems arising from poor methodology. [18] [19] [20] [21] This review was undertaken to systematically evaluate the methodologic quality of, and summarize the evidence from RCTs and controlled clinical trials (CCTs) that have investigated the effectiveness of physical exercise in cancer patients during and after medical treatment. It incorporates several recently published RCTs that were not included in previous reviews, and uses a more structured approach to evaluating the methodologic quality of studies than has been used previously.
METHODS

Search Strategy
A computer-aided search 22 CancerLIT (2004) , and PEDro (all up to June 2004) was performed to identify relevant RCTs and CCTs. CCTs are defined as intervention studies with a control group, but without explicit use of randomization for purposes of group allocation. The following search terms were used: cancer, neoplasm, randomized or randomised, tumor or tumour* (where * is a truncation sign), malignanc*, sports, exercise*, physical activity, graded activity, physical function, body mass, fat-free mass, symptom*, depressive disorder, fatigue, anxiety, depressive, mood status, psychology, and quality of life. The reference lists of the studies identified were searched for additional suitable studies. Furthermore, an effort was made to retrieve unpublished studies, including those with negative results. Toward this end, a letter was sent to 20 experts who had published earlier in the area of physical exercise in cancer inquiring as to whether they or any of their colleagues had any unpublished reports concerning exercise trials among cancer patients that they would be willing to share with us.
No restrictions were made regarding the language of the publication.
Inclusion Criteria and Data Collection
To be included in the review, all RCTs and CCTs had to have examined the effects of physical exercise after surgery or during or after chemotherapy, radiotherapy, and/or hormonal therapy. In this review, an intervention during cancer treatment was defined as one that took place during the time period between the initiation of cancer treatment and either 2 weeks after the last radiation treatment or 4 weeks after the last cycle of chemotherapy. 10 An intervention after cancer treatment was defined as one that took place at least 2 weeks after completion of radiotherapy and/or at least 4 weeks after the last cycle of chemotherapy. Studies were reviewed that used interventions to improve endurance or muscular strength. Examples include walking (either outdoor or on a treadmill), cycling, swimming, and strengthening exercises (using free weights, isokinetic machines, or weight machines), performed either within a hospital-based rehabilitation unit or in a homebased program. Studies of relaxing exercises (eg, yoga or tai-chi) were excluded. Studies using at least one of the following types of outcome were included: oxygen consumption per unit of time (V O 2 maximum or oxygen uptake), fatigue, body composition, exercise levels or level of physical activity, walking distance, psychological distress, or self-reported HRQOL. A P value of less than .05 was used as the criterion for statistically significant results. One reviewer (R.K.) performed the initial search to identify studies that met the eligibility criteria. A senior associate of the library service of the University Hospital Zurich verified this search. Disagreement regarding inclusion of the studies was resolved by consensus between authors (R.K. and J.F.). The arbitration of a third reviewer (N.K.A.), as recommended by van Tulder et al, 23 was to be used in the event of any disagreement between the two reviewers regarding the methodologic quality of a trial.
Assessment of Methodologic Quality
Two reviewers (R.K. and G.A.) independently assessed the methodologic quality of the studies according to the Delphi criteria list, 24 a set of nine criteria for quality assessment: use of randomization; concealment of treatment allocation (ie, concealing the group assignment sequence until a potential study participant has been approached and has provided informed consent); equivalence (or similarity) of groups at baseline regarding the most important prognostic indicators; specification of the eligibility criteria; blinding of the outcome assessors; blinding of the care providers; blinding of the patients; reporting of point estimates and measures of variability for the primary outcome measures; and use of an intention-to-treat analysis. In the current analysis, seven of the nine quality criteria were evaluated. Two of the three criteria relating to the use of blinding procedures were not rated because it is difficult, if not impossible, to blind patients and care providers to treatment assignment. 25 However, blinding of external assessors or raters was included as one of the quality criteria.
For each quality criterion, three rating categories were available: yes, met criteria; no, did not meet criteria; and do not know. Although summary scores across quality criteria are sometimes calculated to classify studies qualitatively as being of high or low quality, the use of such rating procedures in assessing the quality of physical therapy trials has been discouraged because of the absence of clear decision rules for establishing threshold or cutoff scores. 26 Therefore, in this review, the methodologic quality of the identified trials was analyzed and is presented for each quality criterion separately (Tables 1 and 2) .
Percentage agreement and Cohen's Kappa statistic were calculated with GRAPHPAD software (Version 2002; GRAPHPAD Software Inc, San Diego, CA), and were interpreted in accordance with Landis and Koch's benchmarks for assessing the agreement between raters: poor (Ͻ 0), slight (0.0 to 0.20), fair (0.21 to 0.40), moderate (0.41 to 0.60), substantial (0.61 to 0.80), and almost perfect (0.81 to 1.0).
58
RESULTS
Study Characteristics
The literature search yielded 31 reports 27-57 that met the basic eligibility criteria of being either an RCT or a CCT, and in which physical exercise was used as a means of improving physical fitness and/or psychological well-being of cancer patients during or after treatment. Three studies, all from a single source, were added as a result of a direct inquiry sent to authors within the area of research (Schwartz et al, submitted for publication A; Schwartz et al, submitted for publication B; Huang et al, submitted for publication). All of these latter studies had been submitted for publication at the time of inquiry. Of the 34 studies included in the review, 17 RCTs (Schwartz et al, submitted for publication A; Schwartz et al, submitted for publication B; Huang et al, submitted for publication) 27-39, 45 and five CCTs 40-44 examined the effectiveness of physical exercise during medical treatment, whereas 10 RCTs 46-55 and two CCTs 56,57 were focused on the period after medical treatment. The studies during medical treatment were divided into three subcategories: exercise during breast cancer treatment, exercise during bone marrow and peripheral stemcell transplantation, and exercise during medical treatment for mixed solid tumors. The studies after medical treatment were divided into those involving exercise after breast cancer treatment and exercise after medical treatment for other solid tumors. These categories of studies reflect not only differences in cancer diagnosis and the timing of the 
Exercise During Breast Cancer Treatment
Physical exercise was performed during (adjuvant) chemotherapy in five studies (Schwartz, submitted for publication A) [28] [29] [30] [31] ; chemotherapy, radiotherapy, or hormone therapy in one study 34 ; radiotherapy or chemotherapy in two studies 35, 45 ; and radiotherapy alone in one study (Table 3) . 41 The sample sizes ranged from 14 to 123 patients. These studies yielded a wide range of statistically significant outcomes favoring exercise, including body composition (body fat, 29 35 In one study, no statistically significant differences between groups were observed for changes in aerobic capacity, body weight, and self-reported quality-oflife scores.
34
Exercise During High-Dose Chemotherapy Following Bone Marrow and Peripheral Bone Stem-Cell Transplantation
The effect of physical exercise was investigated during high-dose chemotherapy, radiotherapy and bone marrow transplantation (BMT) in one study, 27 during highdose chemotherapy following peripheral bone stem-cell ; and self-reported psychological well-being and mood status. 42 No statistically significant effects were reported for triceps skinfold, arm circumference, nitrogen balance, or 3-methylhistidine excretion. 27 Lymphocytes and cell counts improved but remained lower than normative data.
44
Exercise in a Mixed Solid Tumor Population During Medical Treatment
Five studies investigated the effect of physical exercise among mixed solid tumor populations (Table 5) . These included studies of physical exercise directly after stomach cancer surgery, 33 during hormone therapy, 36 directly after neurectomy in head and neck cancer patients, 39 and in mixed cancer populations beginning chemotherapeutic regimens with catabolic steroids (Schwartz, submitted for publication B; Huang, submitted for publication). The sample sizes ranged from 12 to 155 patients. Positive results were reported for increased physical fitness, 36 aerobic capacity (Schwartz, submitted for publication B), bone mineral density (Schwartz, Statistically significant results were not reported between groups for body composition (including weight, body mass index, waist circumference, and sum of skinfolds), 36 muscle strength (Schwartz, submitted for publication B; Huang, submitted for publication), fatigue (Schwartz, submitted for publication B), and quality of life.
39
Exercise After Breast Cancer Treatment
A wide range of statistically significant outcomes were reported in studies of exercise after breast cancer treatment, including aerobic capacity, 51 cardiopulmonary changes, 52 physical strength, 57 walking distance, 46 and blood pressure (Table 6) . 51 The effects of exercise on insulin-like growth factors (IGF1) 53 and binding proteins (IGFBP-3, IGFBP-1: IGFBP-3 molar ratio) were reported in one study. 53 Statistically significant results were reported for self-reported outcomes including mood status, 51 fatigue, 52 ,56 depression, 56 anxiety, 56 happiness, 52 self-esteem, 52 and quality of life. 50, 52, 57 One study reported the effect of support received from the physicians. 56 Patients who were encouraged by their oncologist exercised significantly more than patients who did not receive such encouragement.
56 Other outcomes for which no statistically significant results were reported included muscle strength, 46 physical capacity, 57 arm circumference, 50 body composition (including weight, body mass index, sum of skinfolds), 52 natural-killer cell cytotoxic activity, 46 fasting insulin, glucose, insulin resistance, IGF2, IGFBP-1, 53 subjects' positive and negative affect, 51 and anxiety. 56 The sample size of these studies ranged from 11 to 60 patients.
Exercise in Mixed Solid Tumor Populations After Medical Treatment
These studies included a mix of patients with breast, colon, ovarian, brain and lung cancer, and non-Hodgkin's lymphoma ( 
Assessment of Methodologic Quality
The reviewers agreed on 288 of 306 methodologic ratings (94.1%). The remaining disagreements were resolved after discussions among the reviewers. The inter-reviewer statistic was 0.88 (95% CI, 0.83 to 0.94). The median criteria score on the Delphi list (range, 1 to 7) was 4 for both studies of exercise during and after cancer treatment (Tables 1 and 2 , respectively). The studies of Segal, 36 Courneya, 52, 54 and Fairey 53 were rated positively on all seven methodologic criteria. Nine of 34 
DISCUSSION
This systematic review summarizes the substantive results and evaluates the methodologic quality of 34 reports of 27 RCTs and seven CCTs of physical exercise programs designed for cancer patients during and after medical treatment. Of the studies conducted during cancer treatment, five RCTs satisfied five of the seven criteria for methodologic quality (Schwartz, submitted for publication A), 27, 32, 35, 38 two RCTs satisfied six of the criteria (Schwartz, submitted for publication B), 34 and one trial 36 satisfied all seven of the criteria. The highest methodologic quality score for a CCT was 4 of 7, found in two trials of physical exercise during the treatment in a mixed solid tumor population. 42, 44 Of the studies examining physical 34) , blinding of the outcome assessor (27 of 34) and failure to employ an intention-to-treat data analysis strategy (19 of 34) . Overall, the RCTs and CCTs included in this review were of moderate methodologic quality. However, there appears to be a trend toward more methodologic rigor in more recent studies. 36, [52] [53] [54] The reporting of future RCTs may be improved if authors provide all of the information requested by the Consort checklist 19 before submitting manuscripts for publication.
The results of this review suggest that cancer patients in specific populations may benefit from physical exercise both during and after cancer treatment. Positive results have been observed for a diverse set of outcomes, including physiologic measures, objective performance indicators, self-reported functioning and symptoms (particularly fatigue), psychological well-being, and overall HRQOL. However, these results need to be interpreted with some caution. Many of the positive outcomes were observed in some, but not all trials. Variability in outcomes may be due to differences in study design (RCT v CCT), sample size and resulting statistical power, and the specific study measures employed. From a substantive perspective, the studies were quite heterogeneous with regard to the nature, intensity, timing, and duration of the exercise program being evaluated. There was also a good deal of variability in the medical context in which the exercise programs were implemented and evaluated. Given that many of the trials reviewed used small sample sizes, we considered statistical pooling of data across trials. This was ultimately deemed not to be feasible because of the heterogeneity in the types of exercise programs investigated, in the types of comparison groups used (eg, placebo, minimal intervention, no intervention), in the outcomes assessed, and in the periods of follow-up.
Quality-of-life and longevity benefits resulting from increased physical activity may vary as a function of the type and stage of cancer, the medical treatment, and the patients' current lifestyle. For example, early-stage breast cancer patients may benefit from a moderate aerobic exercise program, both during and after completion of medical treatment, in terms of the improved physical, functional, and social well-being, reduced symptom distress (particularly fatigue), and increased levels of life satisfaction. Among this population of patients, exercise might be combined with dietary changes (eg, a low-fat diet). Dietary fat reduction can result in a lowering of serum estradiol levels and such dietary modification may contribute to the prevention of breast cancer. 59 Currently, it is unknown whether physical exercise, eventually combined with a low-fat diet, can lower the risk of breast cancer recurrence. This might be investigated by following up certain biomarkers (ie, IGF-1 and IGFBP-3) in women who have participated previously in clinical trial-based exercise programs, or could be studied in future clinical trials. Diet, nutrition, and other lifestyle features affect the expression and production of IGF-1. 60 IGF-1 has potent mitogenic and antiapoptotic properties in normal and malignant breast epithelial cells in vitro, whereas IGFBP-3 restricts the availability and biologic activity of IGF-1. 60 High levels of IGF-1 and low levels of IGFBP-3 are associated with cancer recurrence and adverse prognostic factors. 61 The study by Fairey et al 53 showed that physical exercise has a significant effect on IGF-1 and IGFBP-3 in postmenopausal breast cancer survivors. However, the clinical implications of these findings and their potential impact on overall survival in breast cancer patients remain to be defined.
Patients with breast, 62 colorectal, 63 and prostate 64 cancer who are overweight have been found to be at increased risk of cancer recurrence and death. The results of this review suggest that a physical exercise intervention alone is not sufficient to influence significantly the weight of cancer patients during the period after medical treatment, although one study reported a significant decrease in body fat after a physical exercise intervention. 49 Among survivors of solid tumors, weight loss can probably best be achieved by combining physical exercise with dietary management strategies aimed at promoting healthy eating habits, and strategies for improving body image and self-acceptance. 65 Among patients with advanced disease, a resistive exercise program combined with protein supplements may increase muscle strength and maintain patients' functional ability. 65, 66 The increased efficiency of protein use may be important for wasting diseases such as cancer, particularly in patients suffering from sarcopenia. 67 Self-reported HRQOL improved in the intervention groups in most of the studies reviewed. Although this may be attributed to the exercise programs, it could also be the result of increased attention paid by health care personnel, and might reflect benefits accrued from group activities with fellow patients. 68 Such alternative explanations are particularly relevant in those studies that employed a notreatment control group. Two studies 34,54 employed a research design capable of addressing this issue. Segal et al 34 compared the effects of supervised exercise versus selfdirected exercise versus usual care (control group) among patients undergoing adjuvant chemotherapy or hormonal therapy. HRQOL, as assessed with the Rand 36-item health survey (SF-36), improved significantly over a 26-week period in both the supervised and self-directed exercise groups, whereas it declined in the control group. Posthoc analyses indicated a significant difference between the self-directed and the supervised exercise group in favor of the self-directed exercisers. Courneya et al 54 compared psychotherapy alone with psychotherapy plus a home-based physical exercise program. Significant group differences over time in favor of the combined psychotherapy and exercise group were observed in fatigue and functional well-being. Taken together, the two studies suggest that the salutary effect of physical exercise on patients' HRQOL cannot be attributed to nonspecific program characteristics such as increased attention received from health care providers or support received from fellow patients.
As has been described by Courneya et al 68 the exercise preferences of cancer patients can have an important effect on both their initial motivation to participate in formal physical exercise programs and their adherence to such programs. Adherence of cancer patients to short-term physical exercise interventions is slightly below that of other patient populations, and may explain, in part, the lack of effect observed in some of the studies reviewed. 45 In future RCTs, the motivation of patients and their exercise history should be assessed and perhaps used as either stratification variables before randomization or as covariates in the statistical analysis. Similarly, patients' adherence with exercise programs should be carefully monitored and reported because this may influence significantly the effectiveness of such programs in improving physical and psychosocial health outcomes. 69 In conclusion, this review indicates that many of the RCTs and CCTs undertaken to date to evaluate the efficacy of exercise programs in cancer patients have been of only moderate methodologic quality. However, there appears to be some improvement over time, with the most recent studies evidencing the highest methodologic quality. Although positive results have not always been observed consistently across studies, the general pattern of results indicates that exercise can be effective in reducing symptoms and improving the physical and psychosocial functioning of patients with cancer. It is important to note that the positive effects of exercise may vary significantly as a function of the type of cancer; the stage of disease; the medical treatment; the nature, intensity, and duration of the exercise program; and the lifestyle of the patient. Future RCTs should use larger samples, include appropriate comparison groups to rule out the possibility of an attentionplacebo effect, standardize both the mode and intensity of exercise used, use a comparable set of outcome measures, and pay greater attention to issues of motivation and adherence of patients participating in exercise programs. Finally, studies with longer follow-up are needed to investigate the possible effects of exercise on cancer recurrence and survival.
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